hai Emulsomes Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Emulsomes

Emulsomes


As per available reports about 43 relevant Journals, 29 Conferences  are presently dedicated exclusively to Emulsomes and about 798 articles are being published on Emulsomes.

These are the improvised forms of  poorly soluble drugs. The drug is enclosed in the emulsomes and provide prolong existence of drug in systemic circulation. Furthermore, emulsomal-based formulations of genetic drugs such as antisense oligonucleotides and plasmids for gene therapy that have clear potential for systemic utility are increasingly available. This review addresses the concept of emulsomal drug delivery system, summarizes the success of emulsomes for the delivery of small molecules, and special attention has been paid to its formulation design, advantages, biopharmaceutical aspects, stability aspects, and various aspects related to drug delivery including future aspects. Biocompatible and Biodegradable Nanoparticles as Drug Carriers,niosomes, resealed erythrocytes, nanoparticles,  nanospheres,  naocapsules , and modified Drug Carrier Systems are the wings included in Novel Drug Delivery Systems

Scope and Importance:

Emulsomes is a revolutionary field of micro manufacturing involving physical and chemical changes to produce micro-sized materials. Microsized particles consists of aggregated as well as unbound particles. Microlevel particulate drug delivery  deals with processes that occur at molecular and atomic level.It involves designing, synthesis and characterization of material structure by controlling the shapes and sizes at microscale. Changing the properties of the material such as increase in surface area, dominance of quantum effects often associated with minute sizes, higher surface area to volume ratio etc.

Microparticulate drug delivery systems have designed for chronotherapeutic topical drug delivery but attempts to utilize them for oral, pulmonary and parenteral drug delivery were also made. Researchers have extensively studied their properties and characteristics affecting the drug release and loading. Various advances were made with this carrier particle resulting in the development of various novel development techniques and carrier particles.

The oral route is the easiest, cost effective, and most vital method for drug administration. Therefore, improvement of dosage forms mainly for the prolonged release purpose has been a challenge for scientists. Vesicular drug delivery systems are developed with a purpose to overcome with problems coupled the drugs such a poor bioavailability, protection from harsh gastric environment, and from gastric enzymes, which degrade the drug. Vesicular drug delivery systems such as liposomes, emulsions, niosomes, proniosomes, solid lipid-nano particles, ethosomes, nanoparticles, and pharmacosomes, etc have gained much attention, but emulsomes have rouse as system, which bypasses many disadvantages associated with other systems, developed as novel lipoidal vesicular system with internal solid fat core surrounded by phospholipid bilayer.

This technology is designed to act as vehicle for poorly soluble drugs. The drug is enclosed in the emulsomes and provide prolong existence of drug in systemic circulation. Furthermore, emulsomal-based formulations of genetic drugs such as antisense oligonucleotides and plasmids for gene therapy that have clear potential for systemic utility are increasingly available. This review addresses the concept of emulsomal drug delivery system, summarizes the success of emulsomes for the delivery of small molecules, and special attention has been paid to its formulation design, advantages, biopharmaceutical aspects, stability aspects, and various aspects related to drug delivery including future aspects.

we developed emulsomes, a novel lipoidal vesicular system with an internal solid fat core surrounded by a phospholipid bilayer. Plain emulsomal formulations composed of solid lipid (trilaurin or tristearin), cholesterol and soya phosphatidylcholine and stearylamine containing cationic emulsomes loaded with an antiviral drug (zidovudine) were prepared by a simple cast film method followed by sonication to produce emulsomes of nanometric size range. All different types of formulations were optimized for lipid ratios and characterized in-vitro for shape, morphology, size and in-vitro drug release profile. Emulsomal formulations displayed a sufficiently slow drug release profile (12-15% after 24 h). In-vivo organ distribution studies in rats demonstrated better uptake of emulsomal formulations by the liver cells.

Market Analysis:

The global revenue for advanced drug delivery systems is estimated to be $151.3 billion in 2013. In 2018,  revenues are estimated to reach nearly $173.8 billion, demonstrating a compound annual growth rate (CAGR) of 2.8%. The global market for drug delivery systems in 2010 was $131.6 billion and is expected to increase to $137.8 billion by the end of 2011. The market is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. An overview of the global market for drug delivery systems, including the market as seen by end users of different applications

Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.

International symposium and workshops

  • 17th International Pharmaceutical Technology Symposium
  • International Conference on Industrial Pharmacy
  • British Pharmacological Societies, Dec 13-15, 2016, London, UK

List of Best International Conferences:

  1. 8th Pharmaceutics and Novel Drug Delivery Systems Conference
    March 07-09, 2016 Madrid, Spain
  2. Industrial Pharmacy Conference
    April 28-29, 2016 Dubai, UAE
  3. 4th Medicinal Chemistry and Computer Aided Drug Designing Conference
    December 01-03, 2016 Chicago, USA
  4. 2nd Parenterals and Injectables Conference
    October 24-26, 2016 Istanbul, Turkey
  5. 4th Clinical Pharmacy Conference
    Oct 31 - Nov 01, 2016 Las Vegas, USA
  6. 2nd Drug Discovery and Designing Conference
    Oct 31-Nov 02, 2016 Istanbul, Turkey
  7. 4th Neuropharmacology Conference
    September 15-17, 2016 San Antonio, USA
  8. 7th Pharmacovigilance and Clinical Trials Conference
    September 19-21, 2016 Vienna, Austria
  9. 6th Pharmacovigilance Congress
    August 01-03, 2016 Toronto, Canada
  10. 3rd Pharmacology Congress
    August 08-10, 2016 Birmingham, UK
  11. 6th Annual Drug Delivery & Formulation Americas Summit
    April 14-15, 2016 Costa Mesa, CA, US
  12. 18th International Conference on Pharmaceutical Sciences & Pharmacology
    January 21 - 22, 2016, Paris, France
  13. American Society for Clinical Pharmacology & Therapeutics Annual Meeting
    March 9-12, 2016, California, United States
  14. 7th Annual Global Drug Delivery & Formulation Summit
    May 23-25, 2016 Dusseldorf, Germany
  15. Drug Delivery Partnerships 2016 (DDP 2016)
    January 20-22, 2016 Palm Beach Gardens, FL, US
  16. Peptide Drug Design & Delivery Summit
    February 24-25, 2016 San Francisco, CA, US    

Relevant Society and Associations

  • National Pharmacy Association
  • American Association of Pharmaceutical Scientists
  • American College of Clinical Pharmacology
  • Academy of Managed Care Pharmacy
  • American Association of Colleges of Pharmacy
  • American Society for Clinical Pharmacology and Therapeutics
  • American College of Clinical Pharmacy
  • Arkansas State Board of Pharmacy
  • Association of Pharmacy Technicians UK
  • Austrian Pharmaceutical Society
  • Association of Pharmacy Professionals
  • Pharmaceutical Society of Ireland
  • Pharmaceutical Society Of New Zealand
  • Pharmaceutical Association of Mauritius
  • International Pharmaceutical Federation (FIP)
  • European Pharmaceutical Union (EPU)
  • Pharmaceutical Group of the European Union (PGEU)
  • European Association of Employed Community Pharmacists in Europe (EPhEU)
  • Pharmaceutical Society of Australia
  • Canadian Pharmacists Association
  • Danish Association of Pharmaconomists

Companies

  • AstraZeneca
  • Accredo Therapeutics
  • Actelion Pharmaceuticals US, Inc
  • Bayer HealthCare
  • CRITICAL CARE
  • Cané Medical Technology
  • CVS Caremark
  • CuraScript
  • Fairview Specialty Pharmacy
  • Gilead Sciences
  • Vivisol
  • AIM
  • Henry Schein
  • Snap Diagnostics
  • MediLexicon
  • Nicos Group Inc.
  • Bausch & Lomb Instruments
  • JEDMED
  • Miami Medical
  • Image Stream Medical


 

This page will be updated regularly.

This page was last updated on November 5, 2024

Conference Series Destinations